Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Correction to: Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.

Masoud SJ, Perone JA, Farrow NE, Mosca PJ, Tyler DS, Beasley GM.

Curr Treat Options Oncol. 2019 Aug 29;20(10):76. doi: 10.1007/s11864-019-0674-x.

PMID:
31468223
2.

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.

Bell CC, Fennell KA, Chan YC, Rambow F, Yeung MM, Vassiliadis D, Lara L, Yeh P, Martelotto LG, Rogiers A, Kremer BE, Barbash O, Mohammad HP, Johanson TM, Burr ML, Dhar A, Karpinich N, Tian L, Tyler DS, MacPherson L, Shi J, Pinnawala N, Yew Fong C, Papenfuss AT, Grimmond SM, Dawson SJ, Allan RS, Kruger RG, Vakoc CR, Goode DL, Naik SH, Gilan O, Lam EYN, Marine JC, Prinjha RK, Dawson MA.

Nat Commun. 2019 Jun 20;10(1):2723. doi: 10.1038/s41467-019-10652-9.

3.

Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.

Williams SB, Shan Y, Ray-Zack MD, Hudgins HK, Jazzar U, Tyler DS, Freedland SJ, Swanson TA, Baillargeon JG, Hu JC, Kaul S, Kamat AM, Gore JL, Mehta HB.

JAMA Surg. 2019 Jun 5:e191629. doi: 10.1001/jamasurg.2019.1629. [Epub ahead of print]

PMID:
31166593
4.

Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees.

Hughes BD, Hancock KJ, Shan Y, Thakker RA, Maharsi S, Tyler DS, Mehta HB, Senagore AJ.

J Surg Oncol. 2019 Aug;120(2):280-286. doi: 10.1002/jso.25511. Epub 2019 May 27.

PMID:
31134661
5.

Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.

Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS.

Ann Surg Oncol. 2019 Aug;26(8):2486-2494. doi: 10.1245/s10434-019-07288-w. Epub 2019 Mar 25.

PMID:
30911949
6.

Personality Testing May Identify Applicants Who Will Become Successful in General Surgery Residency.

Hughes BD, Perone JA, Cummins CB, Sommerhalder C, Tyler DS, Bowen-Jallow KA, Radhakrishnan RS.

J Surg Res. 2019 Jan;233:240-248. doi: 10.1016/j.jss.2018.08.003. Epub 2018 Sep 3.

PMID:
30502254
7.

Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.

Masoud SJ, Perone JA, Farrow NE, Mosca PJ, Tyler DS, Beasley GM.

Curr Treat Options Oncol. 2018 Sep 19;19(11):55. doi: 10.1007/s11864-018-0575-4. Review. Erratum in: Curr Treat Options Oncol. 2019 Aug 29;20(10):76.

8.

Development of a Model for Training and Assessing Open Image-Guided Liver Tumor Ablation.

Diab K, Kochat S, McClintic J, Stevenson HL, Agle SC, Olino K, Tyler DS, Brown KM.

J Surg Educ. 2019 Mar - Apr;76(2):554-559. doi: 10.1016/j.jsurg.2018.07.015. Epub 2018 Aug 16.

PMID:
30121166
9.

Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.

Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson TA, Kamat AM.

JAMA Surg. 2018 Oct 1;153(10):881-889. doi: 10.1001/jamasurg.2018.1680.

10.

Contemporary Approaches to In-Transit Melanoma.

Perone JA, Farrow N, Tyler DS, Beasley GM.

J Oncol Pract. 2018 May;14(5):292-300. doi: 10.1200/JOP.18.00063. Review.

11.

Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.

Jazzar U, Yong S, Klaassen Z, Huo J, Hughes BD, Esparza E, Mehta HB, Kim SP, Tyler DS, Freedland SJ, Kamat AM, Wolf DV, Williams SB.

Cancer. 2018 Aug 1;124(15):3127-3135. doi: 10.1002/cncr.31404. Epub 2018 Apr 16.

12.

Cancer and All-cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-making.

Williams SB, Huo J, Chu Y, Baillargeon JG, Daskivich T, Kuo YF, Kosarek CD, Kim SP, Orihuela E, Tyler DS, Freedland SJ, Kamat AM.

Urology. 2017 Dec;110:76-83. doi: 10.1016/j.urology.2017.08.024. Epub 2017 Aug 25.

PMID:
28847688
13.

Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.

Huo J, Chu Y, Chamie K, Smaldone MC, Boorjian SA, Baillargeon JG, Kuo YF, Kerr P, O'Malley P, Orihuela E, Tyler DS, Freedland SJ, Giordano SH, Vikram R, Kamat AM, Williams SB.

Clin Genitourin Cancer. 2017 Jul 26. pii: S1558-7673(17)30215-X. doi: 10.1016/j.clgc.2017.07.018. [Epub ahead of print]

14.

Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment.

Williams SB, Huo J, Dafashy TJ, Ghaffary CK, Baillargeon JG, Morales EE, Kim SP, Kuo YF, Orihuela E, Tyler DS, Freedland SJ, Kamat AM.

Urol Oncol. 2017 Oct;35(10):602.e1-602.e9. doi: 10.1016/j.urolonc.2017.05.022. Epub 2017 Jun 21.

PMID:
28647395
15.

Click chemistry enables preclinical evaluation of targeted epigenetic therapies.

Tyler DS, Vappiani J, Cañeque T, Lam EYN, Ward A, Gilan O, Chan YC, Hienzsch A, Rutkowska A, Werner T, Wagner AJ, Lugo D, Gregory R, Ramirez Molina C, Garton N, Wellaway CR, Jackson S, MacPherson L, Figueiredo M, Stolzenburg S, Bell CC, House C, Dawson SJ, Hawkins ED, Drewes G, Prinjha RK, Rodriguez R, Grandi P, Dawson MA.

Science. 2017 Jun 30;356(6345):1397-1401. doi: 10.1126/science.aal2066. Epub 2017 Jun 15.

16.

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

Beasley GM, Hu Y, Youngwirth L, Scheri RP, Salama AK, Rossfeld K, Gardezi S, Agnese DM, Howard JH, Tyler DS, Slingluff CL Jr, Terando AM.

Ann Surg Oncol. 2017 Sep;24(9):2728-2733. doi: 10.1245/s10434-017-5883-6. Epub 2017 May 15.

PMID:
28508145
17.

Gastric Neoplasms.

Olino KL, Tyler DS.

Surg Clin North Am. 2017 Apr;97(2):xv-xvi. doi: 10.1016/j.suc.2017.02.001. Epub 2017 Feb 13. No abstract available.

PMID:
28325200
18.

Who did the case? Perceptions on resident operative participation.

Perone JA, Fankhauser GT, Adhikari D, Mehta HB, Woods MB, Strohmeyer JH, Tyler DS, Brown KM.

Am J Surg. 2017 Apr;213(4):821-826. doi: 10.1016/j.amjsurg.2016.11.002. Epub 2016 Nov 12.

19.

What is the OPTiMal Way to Manage In-Transit Disease?

Olino K, Tyler DS.

Ann Surg Oncol. 2016 Dec;23(13):4126-4129. Epub 2016 Jul 5. No abstract available.

PMID:
27380046
20.

It depends on your perspective: Resident satisfaction with operative experience.

Perone JA, Fankhauser GT, Adhikari D, Mehta HB, Woods MB, Tyler DS, Brown KM.

Am J Surg. 2017 Feb;213(2):253-259. doi: 10.1016/j.amjsurg.2016.09.042. Epub 2016 Oct 8.

21.

Finish Line or Beginning? Welcome the New Board-certified Surgical Oncologists.

Tyler DS, Michelassi F.

Ann Surg Oncol. 2016 May;23(5):1403-8. doi: 10.1245/s10434-016-5110-x. Epub 2016 Feb 24. No abstract available.

PMID:
26912027
22.

Neoadjuvant use of ipilimumab in locally advanced melanoma.

Howie LJ, Tyler DS, Salama AK.

J Surg Oncol. 2015 Dec;112(8):841-3. doi: 10.1002/jso.24079.

PMID:
26768512
23.

Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial.

Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS.

J Am Coll Surg. 2016 Mar;222(3):253-60. doi: 10.1016/j.jamcollsurg.2015.11.010. Epub 2015 Nov 25.

24.

Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma.

Brys AK, Bhatti L, Bashir MR, Jaffe TA, Beasley GM, Nath NS, Salama AK, Tyler DS, Mosca PJ.

Ann Surg Oncol. 2016 Apr;23(4):1090-5. doi: 10.1245/s10434-015-4972-7. Epub 2015 Nov 16.

PMID:
26572755
25.

Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.

Nussbaum DP, Adam MA, Youngwirth LM, Ganapathi AM, Roman SA, Tyler DS, Sosa JA, Blazer DG 3rd.

Ann Surg Oncol. 2016 Mar;23(3):1026-33. doi: 10.1245/s10434-015-4937-x. Epub 2015 Nov 5.

PMID:
26542590
26.

Pump-probe imaging of pigmented cutaneous melanoma primary lesions gives insight into metastatic potential.

Robles FE, Deb S, Wilson JW, Gainey CS, Selim MA, Mosca PJ, Tyler DS, Fischer MC, Warren WS.

Biomed Opt Express. 2015 Aug 27;6(9):3631-45. doi: 10.1364/BOE.6.003631. eCollection 2015 Sep 1.

27.

Feeding jejunostomy tube placement during resection of gastric cancers.

Sun Z, Shenoi MM, Nussbaum DP, Keenan JE, Gulack BC, Tyler DS, Speicher PJ, Blazer DG 3rd.

J Surg Res. 2016 Jan;200(1):189-94. doi: 10.1016/j.jss.2015.07.014. Epub 2015 Jul 16.

28.

Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma.

Lane WO, Cramer CK, Nussbaum DP, Speicher PJ, Gulack BC, Czito BG, Kirsch DG, Tyler DS, Blazer DG 3rd.

J Surg Oncol. 2015 Sep;112(4):352-8. doi: 10.1002/jso.23996. Epub 2015 Aug 4.

PMID:
26238282
29.

Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.

Sun Z, Nussbaum DP, Speicher PJ, Czito BG, Tyler DS, Blazer DG 3rd.

J Surg Oncol. 2015 Jul;112(1):46-50. doi: 10.1002/jso.23957. Epub 2015 Jul 14.

PMID:
26179329
30.

Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.

Holtzhausen A, Zhao F, Evans KS, Tsutsui M, Orabona C, Tyler DS, Hanks BA.

Cancer Immunol Res. 2015 Sep;3(9):1082-95. doi: 10.1158/2326-6066.CIR-14-0167. Epub 2015 Jun 3.

31.

Gangrenous cholecystitis: a contemporary review.

Ganapathi AM, Speicher PJ, Englum BR, Perez A, Tyler DS, Zani S.

J Surg Res. 2015 Jul;197(1):18-24. doi: 10.1016/j.jss.2015.02.058. Epub 2015 Mar 4.

PMID:
25937567
32.

Management of 1- to 2-cm Carcinoid Tumors of the Appendix: Using the National Cancer Data Base to Address Controversies in General Surgery.

Nussbaum DP, Speicher PJ, Gulack BC, Keenan JE, Ganapathi AM, Englum BR, Tyler DS, Blazer DG 3rd.

J Am Coll Surg. 2015 May;220(5):894-903. doi: 10.1016/j.jamcollsurg.2015.01.005. Epub 2015 Jan 22.

PMID:
25840530
33.

Regional therapies for in-transit disease.

Speicher PJ, Meriwether CH, Tyler DS.

Surg Oncol Clin N Am. 2015 Apr;24(2):309-22. doi: 10.1016/j.soc.2014.12.008. Epub 2015 Jan 30. Review.

34.

Outcomes following splenectomy in patients with myeloid neoplasms.

Rialon KL, Speicher PJ, Ceppa EP, Rendell VR, Vaslef SN, Beaven A, Tyler DS, Blazer DG 3rd.

J Surg Oncol. 2015 Mar 15;111(4):389-95. doi: 10.1002/jso.23846. Epub 2014 Dec 9.

PMID:
25488568
35.

Patterns of failure for stage I ampulla of Vater adenocarcinoma: a single institutional experience.

Zhong J, Palta M, Willett CG, McCall SJ, McSherry F, Tyler DS, Uronis HE, Czito BG.

J Gastrointest Oncol. 2014 Dec;5(6):421-7. doi: 10.3978/j.issn.2078-6891.2014.084.

36.

Laparoscopic duodenectomy for benign nonampullary duodenal neoplasms.

Kokosis G, Ceppa EP, Tyler DS, Pappas TN, Perez A.

Surg Laparosc Endosc Percutan Tech. 2015 Apr;25(2):158-62. doi: 10.1097/SLE.0000000000000106.

PMID:
25304734
37.

Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK, Perkins SM, Speicher PJ, Tyler DS, Konger RL, Travers JB.

Cancer Res. 2014 Dec 1;74(23):7069-78. doi: 10.1158/0008-5472.CAN-14-2043. Epub 2014 Oct 10.

38.

Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.

Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA.

Ann Surg. 2014 Oct;260(4):601-5; discussion 605-7. doi: 10.1097/SLA.0000000000000925.

39.

Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.

Muilenburg DJ, Beasley GM, Thompson ZJ, Lee JH, Tyler DS, Zager JS.

Ann Surg Oncol. 2015 Feb;22(2):482-8. doi: 10.1245/s10434-014-4072-0. Epub 2014 Sep 6.

40.

Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas.

Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Englum BR, Kirsch DG, Tyler DS, Blazer DG 3rd.

Ann Surg. 2015 Jul;262(1):163-70. doi: 10.1097/SLA.0000000000000840.

41.

A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion.

Beasley GM, Speicher P, Augustine CK, Dolber PC, Peterson BL, Sharma K, Mosca PJ, Royal R, Ross M, Zager JS, Tyler DS.

Ann Surg Oncol. 2015 Jan;22(1):287-94. doi: 10.1245/s10434-014-3887-z. Epub 2014 Aug 22.

42.

Quality of life after isolated limb infusion for in-transit melanoma of the extremity.

Jiang BS, Speicher PJ, Thomas S, Mosca PJ, Abernethy AP, Tyler DS.

Ann Surg Oncol. 2015 May;22(5):1694-700. doi: 10.1245/s10434-014-3979-9. Epub 2014 Aug 14.

43.

The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas.

Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Keenan JE, Stinnett SS, Kirsch DG, Tyler DS, Blazer DG 3rd.

Surg Oncol. 2014 Sep;23(3):155-60. doi: 10.1016/j.suronc.2014.07.001. Epub 2014 Jul 23. Review.

44.

A standardized care plan is associated with shorter hospital length of stay in patients undergoing pancreaticoduodenectomy.

Nussbaum DP, Penne K, Stinnett SS, Speicher PJ, Cocieru A, Blazer DG 3rd, Zani S, Clary BM, Tyler DS, White RR.

J Surg Res. 2015 Jan;193(1):237-45. doi: 10.1016/j.jss.2014.06.036. Epub 2014 Jun 26.

PMID:
25062813
45.

Feeding jejunostomy tube placement in patients undergoing pancreaticoduodenectomy: an ongoing dilemma.

Nussbaum DP, Zani S, Penne K, Speicher PJ, Stinnett SS, Clary BM, White RR, Tyler DS, Blazer DG 3rd.

J Gastrointest Surg. 2014 Oct;18(10):1752-9. doi: 10.1007/s11605-014-2581-6. Epub 2014 Jun 25.

PMID:
24961442
46.

Oncolytic polio virotherapy of cancer.

Brown MC, Dobrikova EY, Dobrikov MI, Walton RW, Gemberling SL, Nair SK, Desjardins A, Sampson JH, Friedman HS, Friedman AH, Tyler DS, Bigner DD, Gromeier M.

Cancer. 2014 Nov 1;120(21):3277-86. doi: 10.1002/cncr.28862. Epub 2014 Jun 17. Review.

47.

Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy.

Speicher PJ, Nussbaum DP, White RR, Zani S, Mosca PJ, Blazer DG 3rd, Clary BM, Pappas TN, Tyler DS, Perez A.

Ann Surg Oncol. 2014 Nov;21(12):4014-9. doi: 10.1245/s10434-014-3839-7. Epub 2014 Jun 13.

PMID:
24923222
48.

Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance?

Speicher PJ, Nussbaum DP, Scarborough JE, Zani S, White RR, Blazer DG 3rd, Mantyh CR, Tyler DS, Clary BM.

HPB (Oxford). 2014 Dec;16(12):1068-73. doi: 10.1111/hpb.12275. Epub 2014 May 23.

49.

Two-day lymphoscintigraphic imaging for melanoma.

Oldan JD, James OG, Mosca PJ, Tyler DS, Borges-Neto S.

Nucl Med Commun. 2014 Aug;35(8):870-5. doi: 10.1097/MNM.0000000000000136.

PMID:
24781011
50.

Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma.

Jiang BS, Beasley GM, Speicher PJ, Mosca PJ, Morse MA, Hanks B, Salama A, Tyler DS.

Ann Surg Oncol. 2014 Aug;21(8):2525-31. doi: 10.1245/s10434-014-3671-0. Epub 2014 Apr 4.

Supplemental Content

Loading ...
Support Center